Prevalence and correlates of physical inactivity in adults across 28 European countries.


Journal

European journal of public health
ISSN: 1464-360X
Titre abrégé: Eur J Public Health
Pays: England
ID NLM: 9204966

Informations de publication

Date de publication:
11 10 2021
Historique:
pubmed: 18 5 2021
medline: 11 11 2021
entrez: 17 5 2021
Statut: ppublish

Résumé

Physical activity/inactivity is impacted by a plethora of intertwined factors. There are a limited number of studies on physical activity/inactivity that provide a European cross-country perspective. This study aims to present the prevalence and correlates of physical activity in adults across the 28 European Union (EU) member states. This is a secondary dataset analysis of the Special Eurobarometer 472 data on physical activity. The cross-sectional survey was conducted during December 2-11 in 2017 across 28 European countries. The data consisted of ∼1000 respondents aged ≧15 years per country. The current analysis was restricted to adults aged 18-64 years (n = 19 645). More than one in three (36.2%, 95% CI: 35.1-37.3) adults in the EU were physically inactive, with substantial cross-country differences noted. Women were less likely than men to be adequately or highly physically active (aOR: 0.86, 95% CI: 0.78-0.95). Similarly, adults at the age of 40-54 (aOR: 0.65, 95% CI: 0.52-0.81) and 55-64 (aOR: 0.61, 95% CI: 0.49-0.77) were less likely to have moderate or high levels of physical activity in comparison with those 18-24 years of age. Finally, high SES was positively associated with physical activity (aOR: 1.4, 95% CI: 1.16-1.69). A notable percentage of adults in Europe are physically inactive. Further research is needed to elucidate the factors behind the cross-country differences and identify potential policy actions that may support adopting a physically active lifestyle and decrease the inequalities related to physical activity across Europe.

Sections du résumé

BACKGROUND
Physical activity/inactivity is impacted by a plethora of intertwined factors. There are a limited number of studies on physical activity/inactivity that provide a European cross-country perspective. This study aims to present the prevalence and correlates of physical activity in adults across the 28 European Union (EU) member states.
METHODS
This is a secondary dataset analysis of the Special Eurobarometer 472 data on physical activity. The cross-sectional survey was conducted during December 2-11 in 2017 across 28 European countries. The data consisted of ∼1000 respondents aged ≧15 years per country. The current analysis was restricted to adults aged 18-64 years (n = 19 645).
RESULTS
More than one in three (36.2%, 95% CI: 35.1-37.3) adults in the EU were physically inactive, with substantial cross-country differences noted. Women were less likely than men to be adequately or highly physically active (aOR: 0.86, 95% CI: 0.78-0.95). Similarly, adults at the age of 40-54 (aOR: 0.65, 95% CI: 0.52-0.81) and 55-64 (aOR: 0.61, 95% CI: 0.49-0.77) were less likely to have moderate or high levels of physical activity in comparison with those 18-24 years of age. Finally, high SES was positively associated with physical activity (aOR: 1.4, 95% CI: 1.16-1.69).
CONCLUSIONS
A notable percentage of adults in Europe are physically inactive. Further research is needed to elucidate the factors behind the cross-country differences and identify potential policy actions that may support adopting a physically active lifestyle and decrease the inequalities related to physical activity across Europe.

Identifiants

pubmed: 34000007
pii: 6277121
doi: 10.1093/eurpub/ckab067
pmc: PMC8504996
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

840-845

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press on behalf of the European Public Health Association.

Références

Int J Public Health. 2016 Jun;61(5):573-82
pubmed: 27042830
Prev Med. 2015 Dec;81:87-91
pubmed: 26299619
Public Health Nutr. 2012 Nov;15(11):2100-9
pubmed: 22717373
Scand J Med Sci Sports. 2012 Jun;22(3):439-47
pubmed: 21039899
Health Promot Int. 2002 Sep;17(3):235-46
pubmed: 12147638
J Public Health Res. 2015 Mar 26;4(1):406
pubmed: 25918694
Prev Med. 2011 Mar-Apr;52(3-4):247-9
pubmed: 21338622
BMC Geriatr. 2018 Apr 16;18(1):94
pubmed: 29661154
J Sch Health. 2004 Feb;74(2):59-65
pubmed: 15077500
Women Health. 1992;19(4):15-29
pubmed: 1295266
PLoS One. 2015 Feb 11;10(2):e0118293
pubmed: 25671621
BMC Public Health. 2012 Sep 19;12:807
pubmed: 22992438
Int J Environ Res Public Health. 2018 May 05;15(5):
pubmed: 29734745
BMC Public Health. 2019 Dec 12;19(1):1677
pubmed: 31830956
Med Sci Sports Exerc. 2013 Feb;45(2):278-85
pubmed: 22903137
Eur J Sport Sci. 2014;14 Suppl 1:S462-70
pubmed: 24175729
PeerJ. 2016 Jun 02;4:e2066
pubmed: 27280072
Int J Behav Nutr Phys Act. 2011 Oct 21;8:115
pubmed: 22018588
Prev Med. 2015 Dec;81:333-8
pubmed: 26449407
Int J Behav Nutr Phys Act. 2017 Jul 24;14(1):99
pubmed: 28738832
Public Health Nutr. 2011 Feb;14(2):246-54
pubmed: 20236565
PLoS One. 2015 Aug 28;10(8):e0135651
pubmed: 26317865
Int J Behav Nutr Phys Act. 2019 Dec 3;16(1):121
pubmed: 31796070
Lancet Glob Health. 2018 Oct;6(10):e1077-e1086
pubmed: 30193830
Int J Public Health. 2007;52(1):8-15
pubmed: 17966815
Scand J Med Sci Sports. 2005 Apr;15(2):107-12
pubmed: 15773865

Auteurs

Katerina Nikitara (K)

School of Medicine, University of Crete, Heraklion, Greece.

Satomi Odani (S)

School of Medicine, University of Crete, Heraklion, Greece.

Nektarios Demenagas (N)

School of Medicine, University of Crete, Heraklion, Greece.

George Rachiotis (G)

Department of Hygiene and Epidemiology, Medical Faculty, University of Thessaly, Larissa, Greece.

Emmanouil Symvoulakis (E)

School of Medicine, University of Crete, Heraklion, Greece.

Constantine Vardavas (C)

School of Medicine, University of Crete, Heraklion, Greece.
Department of Oral Health Policy and Epidemiology, Harvard School of Dental Medicine, Boston, MA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH